SVRA ($SVRA) Insider Trading & Smart Money Activity

SVRA · Biotechnology · Latest filing Jun 22, 2026

$SVRA has 2 insider trades on file. Insiders filed 2 Form 4 transactions in the last 12 months, none of them open-market purchases or sales.

Insider buyers (12 mo)
0
Insider sellers (12 mo)
0
Net insider $ (12 mo)
$0
Congress trades (12 mo)
0
13F moves on file
0
Analyst ratings on file
0

SVRA insider buying and selling by quarter

QuarterInsider buysInsider salesCongress buys / sales13F added / cut
Q1 2026 0 0 0 / 0 0 / 0
Q2 2026 0 0 0 / 0 0 / 0
Q3 2026 0 0 0 / 0 0 / 0
Q4 2026 0 0 0 / 0 0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All SVRA insider, congress, 13F and analyst activity

DateSourceWhoActionSharesValue / amount ΔOwn1W1M6MFilingStory
Insider David LowranceChief Financial Officer Sell (Tax withholding) 185.66K sh $1.02M —
Insider David LowranceChief Financial Officer Buy (Option exercise) 580.19K sh $1.02M —

1W / 1M / 6M = how SVRA moved from the trade or filing date.

Insider trading in SVRA: who is buying and selling

InsiderRoleTradesOpen-market netShares heldLast trade
David Lowrance Chief Financial Officer 2 — Jun 22, 2026

Frequently asked questions

What is the latest insider trade in SVRA?

David Lowrance, Chief Financial Officer filed a sell (tax withholding) of 185.66K sh worth $1.02M on Jun 22, 2026.

Other biotechnology stocks

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text